Fibroids Flashcards

1
Q

What is the risk of sarcomatous change in fibroids?

A

0.2% or 2/1000 women having surgery for fibroids have sarcoma on histology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Management of fibroids

A

Medical (non-hormonal):

  • TXA
  • NSAIDS / mefanamic acid

Medical (hormonal):

  • COCP
  • POP
  • Depo
  • Mirena
  • GnRH agonist (max 6 months)

Minimally invasive:

  • MRgFUS
  • Uterine artery embolisation
  • Bipolar radio frequency ablation (hysteroscopic or laparoscopic)
  • Laparoscopic or US doppler guided occlusion of uterine artery

Surgical (uterine preserving):

  • Myosure/hysteroscopic resection
  • Laparoscopic resection
  • Myomectomy

Surgical (non-uterine preserving):
- Hysterectomy

NB. most of the “minimally invasive” category are still being assessed for their effects on fertility, and should not be considered first-line for women wishing to preserve fertility as we don’t yet know if they improve or reduce fertility rates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pros and cons of uterine preserving management?

A

pros:
- Maintain fertility
- Usually less invasive with faster recovery
- Effective for managing symptoms of fibroids

Cons:
- 20-30% patients will require further treatment within 2 years due to recurrence of fibroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Is there evidence to support myomectomy prior to fertility treatment?

A
  • Removal of the intracavity portion of fibroid improves fertility (RR 1.72)
  • Subserosal fibroids have no effect on fertility
  • Intramural fibroids affect fertility, particularly if they distort the cavity - but no evidence that their removal improves live brith rates, and potential operative risk of requiring hysterectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the classification systems for submucosal fibroids?

A

ESGE and FIGO
0 - pedunculated
1 - < 50% in myometrium
2 - >50% in myometrium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does Ullipristal acetate work?

A

NB. NO longer used due to concerns for liver failure in prolonged use!

  • It is a selective progesterone receptor modulator (SPRM)
  • reversibly blocks progesterone receptor in endometrium and myometrium, and inhibits ovulation whilst having little effect on steroid synthesis and circulating oestrogen levels
  • It reduces the size of fibroids and improves bleeding - effects comparable to GnRH analogues, but better tolerated and less associated with problematic hot flashes
  • It can be taken prior to surgery or on its own
  • Dose 5mg OD for up to 3 months ; maximum 4 cycles (the most cycles assessed during studies)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the quoted outcomes for hysteroscopic resection of fibroids?

A
  • 80% reduction in bleeding
  • 40-60% improvement in fertility
  • 1-2% risk of perforation
  • 1% risk of severe hyponatremia (suspect if >1L glycine or >2L normal saline deficit)
  • infection, bleeding etc
  • 10% require retreatment within 2 years, 30% require retreatment within 5 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Outcomes after myomectomy?

A
  • 80% reduction in bleeding
  • Effective reduction in uterine size and pressure symptoms
  • If over 41 years, effect on fertility is not proven
  • <1% risk hysterectomy
  • 20-30% require pretreatment within 2-5 years
  • Risks and recovery comparable to hysterectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is UAE done?
What are the contraindications?

A
  • Radiologically guided procedure
  • Local anaesthetic and sedation
  • Access via femoral artery to catheterise uterine artery
  • Occlusive particles (polyvinyl) injected to uterine artery, causing occlusion and necrosis of fibroids

Contraindications:
- pelvic infection
- Pelvic malignancy
Relative:
- Pedunculated fibroids - can slough off and cause necrosis and infection within peritoneal cavity or uterine cavity
- SM fibroids (as above)
- Post-menopausal
- Recent GnRH analogue use
- previous UAE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the risks and benefits of UAE?

A

Benefits:

  • 80-90% women report reduction in bleeding
  • reduction in size
  • uterus preserving, but effect on fertility unclear
  • Minimally invasive
  • Day case with quick recovery

Risks:
Early
- pain
- Allergy or ADR to contrast
- haematoma or bleeding at entry site
- Other organ embolisation (most commonly vagina causing pain and sexual dysfunction, or ovary causing menopause)
- Pulmonary embolism
- Post embolisation syndrome (low grade fever, pain, fatigue N&V - peaks 48hr post procedure)
- Pelvic abscess or endometritis +/- sepsis
- Expulsion of necrotic fibroid or prolonged foul smelling discharge
- 5% require hysterectomy within first month due to treatment complications or failure

Late:

  • 2-8% risk of precipitate menopause due to premature ovarian failure
  • 35% require hysterectomy at 10 years for treatment failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the key findings of the EMMY trial?

A
  • 5% UAE patients required hysterectomy in first month due to complications or failure
  • 35% UAE patients required hysterectomy within 10 years
  • 65% were saved a hysterectomy
  • High rate of reintervention in the UAE group negated any cost benefit of Use over hysterectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Would you recommend UAE or myomectomy for someone wanting to preserve fertility? And why?

A

Myomectomy.

  • Significantly higher live birth rates
  • Lower risk of recurrent miscarriage
  • UAE 2-8% risk precipitate menopause (AFC and AMH significantly reduced at 3 months; in age <40 it usually recovers, but frequently doesn’t if > 40 yo)
  • Risk of devacularising myometrium and endometrium affecting implantation
  • Other obstetric and perinatal outcomes comparable between both groups
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the risks/complications of fibroids?

A

obstetric - infertility, miscarriage, abdominal pain (red degeneration of fibroids midtrimester), preterm labour, malpresentation, caesarean delivery, postpartum haemorrhage

Hyaline degeneration is relatively common and presents as painful enlarged fibroids due to hyaline/cystic degeneration pathological process.
Red degeneration (necrobiosis) occurs typically during pregnancy due to infarction at mid-pregnancy.
Calcification (‘womb stone’) - usually in postmenopausal women, occurs as the end point of degeneration.
Sarcomatous (malignant) change. Generally presents as a 0.2% risk. There is a greater risk in women with multiple or rapidly growing fibroids, postmenopausal status, retinoblastoma gene, increasing size despite UAE

Infection (abscess) - relatively rare.
Torsion of pedunculated fibroids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the prevalence of fibroids?

A

70-80% by 50 yo

Increases with increasing age towards the menopause.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the risk factors for fibroids?

A

Black African - Caribbean ethnicities at highest risk - 2-3 fold increased risk
Increasing age (till menopause)
premenopausal status
family hx
time since last birth
consumption of soy bean products and food additives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are protective factors against fibroids?

A

multi parity,
smoking if low BMI,
COCP or depo use.

17
Q

Histology of fibroids.

A

comprise uterine smooth muscle cells and fibroblasts. They contain a large amount of extracellular matrix (including collagen, proteoglycan, fibronectin) and are surrounded by a thin pseudocapsule of areolar tissue and compressed muscle fibers.

18
Q

What are the key consideration when deciding management for fibroids?

A
  • Wanting to maintain fertility
  • Wanting to maintain uterus
  • Size: uterus >20wk, multiple fibroid >5cm - will likely require hysterectomy for successful treatment
  • Previous surgeries / BMI / medical co-morbidities
  • Previous treatments for fibroids ??effective
  • Risk of further surgery requirement - <1% open myomectomy converts to TAH, up to 5% UAE needs early surgical intervention for complications, with 35% surgical intervention for failure at 10 years
19
Q

What is the role of GnRH agonists in fibroid management?

A
  • Can be used up to 6 months as a second line hormonal medical management - not a long term option
  • Can be used for 3-4 months preopertaively to improve surgical outcomes
20
Q

What are the benefits of GnRH pretreatment prior to surgery for fibroids?

A
  • Increase Hb pre-operatively
  • Reduce uterine size - can mean pfannenstiel rather than midline, or laparoscopic procedure
  • Reduce operative blood loss
21
Q

What increases the risk/suspicion for sarcomatous change?

A
  • There is a greater risk in women with multiple or rapidly growing fibroids, postmenopausal status, retinoblastoma gene, increasing size despite UAE
22
Q

What is the FIGO Leiomyoma Subclassification System?

A

Submucous SM (0-2) vs Other O (4-8) 0 - Pedunculated intracavity 1 - <50% intramural 2 - >/=50% intramural 3 - Contacts endometrium, 100% intramura 4 - Intramural 5 - Subserous >/= 50% intramura 6 - Subserous < 50% intramural 7 - Subserous pedunculated 8 - Other (specify, e.g. cervical)

23
Q

Which fibroids are associated with reduced fertility and increased miscarriage rate?

A

Submucosal ARE Intramural MAY be Subserosal are NOT

24
Q

What are three indications for myomectomy in infertile women?

A
  1. Infertile women and those undergoing ART who have SM fibroids 2. Infertile women with symptomatic fibroids 3. Couple presenting with multiple failed cycles of ART where the female partner has IM fibroids
25
Q

How is Uterine Artery embolisation done?

A

Placement of angiographic catheter into the uterine arteries Via the common femoral artery Injection of embolism particles until the flow becomes sluggish in both uterine arteries

26
Q

What is the aim of uterine artery embolisation?

A

To reduce blood flow at the arteriolar levels Producing ischaemia injury to the fibroids Causing necrosis and shrinkage Whilst allowing the surrounding normal myometrium to recover under supply of vaginal and ovarian collateral circulations

27
Q

What were the Cochrane review findings, on UAE vs surgical management (myoemctomy / hysterectomy) for HMB? (6)

A
  1. No significant difference in patient satisfaction at both 2 years and 5 years 2. Similar intra-procedural complications 3. No difference in short- or long-term major complications 4. UAE had a significantly reduced o Length of procedure o Length of hospitalisation o Time to resumption of normal activities 5. UAE had an increased o Rate of short- and long-term minor complications o Number of unplanned reviews and re-admissions after discharge (OR 2.2-2.8) o Surgical re-intervention rate (OR 3.7 at 2 years; 5.8 at 5 years) 6. There was no difference in long-term ovarian failure rates (based on FSH) 7. Myomectomy may have a greater chance of success in women wanting to achieve pregnancy, but the quality of evidence is poor for pregnancy rates, live birth rates and miscarriage rates
28
Q

What are procedural complications of UAE?

A

Groin haematoma Arterial thrombosis Pseudo-aneurysm

29
Q

What are the late complications of UAE?

A

Ovarian insufficiency Failure of response Need for re-intervention

30
Q

What are the pregnancy outcomes after UAE?

A

No difference in PTB, IUGR, mal presentation Significantly higher rates of CS, PPH, miscarriage

31
Q

What are contraindications to UAE?

A
  1. Current pregnancy 2. Recent or current pelvic infection Relative contra-indication 3. Narrow-stalked, pedunculated and large intra-cavity submucosal fibroids - at risk of detaching and sloughing into the endometrial cavity, leaving to cervical obstruction and occasionally seps
32
Q

What is the optimal imaging to evaluate uterine fibroids?

A

MRI Sonohysterography Hysteroscopy (this may under-represent SM lesions because of raised intra-uterine pressure) HSG and TV USS are insufficiently sensitive or specific RANZCOG Guideline

33
Q

Is medical management of fibroids in the context of infertility recommended?

A

No It delays efforts to conceive However, shorter term use of a GnRH analogue can be useful for pre-operative correction of anaemia or short term reduction in fibroid volume RANZCOG Guideline

34
Q

For women that have umbilical artery embolisation for fibroids with HMBN, what % will go on to have a hysterectomy within 10 years?

A

35%

35
Q

What are fertility outcomes for women with fibroids, treated with UAE vs myomectomy?

A

UAED group, significantly - lower pregnancy rates - higher miscarriage rates

36
Q

What is MRgFUS? What are the advantages and disadvantages of this therapy?

A

MRI guided focused Ultrasound Management option for Uterine fibroids / HMB in PREmenopausal women who have completed their families Thermoablative technique: uses ultrasound pulses to heat and destroy fibroid tissue Advantages - Noninvasive - Uterus preserving, potentially could conceive - Short recovery time - MAY restore / preserve fertility but no long term data Disadvantages - low rate of complications - nephrogenic systemic fibrosis from gadolinium contrast. Rare, usually in pre-existing CKD - skin burns - bowel injury, nerve injury and damage